Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma

Neuroblastoma (NBL) is a childhood malignancy of the sympathetic nervous system. For high-risk NBL patients, the mortality rate is still over 50%, despite intensive multimodal treatment. Anti-GD2 monoclonal antibody (mAB) in combination with systemic cytokine immunotherapy has shown clinical efficac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Kroesen, Michiel, Büll, Christian, Gielen, Paul R., Brok, Ingrid C., Armandari, Inna, Wassink, Melissa, Looman, Maaike W. G., Boon, Louis, den Brok, Martijn H., Hoogerbrugge, Peter M., Adema, Gosse J.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4938306/
https://ncbi.nlm.nih.gov/pubmed/27471639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1164919
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!